product approval

FDA Approves First Treatment for Frequent Urination at Night Due to Overproduction of Urine

The U.S. Food and Drug Administration today approved Noctiva (desmopressin acetate) nasal spray for adults who awaken at least two times per night to urinate due to a condition known as nocturnal polyuria (overproduction of urine during the night). Noctiva is the first FDA-approved treatment for this condition.  “Today’s approval provides adults who overproduce urine at night with the first FDA-approved therapeutic option to help reduce the number of times a night they wake up to urinate,” said Hylton V. Joffe, M.D., M.M.Sc., director of the Division of Bone, Reproductive, and Urologic Products in the FDA’s Center for Drug Evaluation and Research. “It is important to know that Noctiva is not approved for all causes of night-time urination, so patients should discuss their symptoms with their health care provider who can determine the underlying cause of the night-time urination and whether Noctiva is right for them.”  Read more.

Source: US FDA, March 3, 2017

Nocturia – Nighttime Trips to the Bathroom

nocturia

If you find yourself having to wake up several times during the night to go to the bathroom, you have a condition that is called nocturia.

While most adults are able to sleep 6 – 8 hours a night, you may find yourself having to wake up several times during the night to go to the bathroom. This is a condition called nocturia.*

Nocturia can leave you feeling like you were up all night long, and you may feel extremely tired when morning arrives. Nocturia negatively affects a person’s quality of life by interrupting sleep, increasing the risk of nighttime falls, causing fatigue and/or depression, and decreasing work efficiency, among other possible problems. Men are much more frequently affected by nocturia than women are, and those who have difficulty walking are at increased risk of injury. Nocturia is also highly prevalent in individuals over 60 years of age.Continue reading